It has been reported that FTX was commonly upregulated in several human cancers and closely participate in tumor behaviors to promote cancer progression including hepatocellular carcinoma [24], lung adenocarcinoma [25], and gastric cancer [26]. This evidence concerns the gene FTX and gastric cancer.